середа, 31 травня 2017 р.

Doctors have expanded the list of deadly drugs

List hazardous to human health and life Medicine was based on the results of studies conducted between 2010 and 2013. Clinicians have decided to add a further 68 drugs with unfavorable characteristics. According to experts, the ratio of "risk-benefit" from these drugs varies towards risk in all clinical situations for which these funds are shown.

 Doctors have expanded the list of deadly drugs  dangerous drugs

Cautionary recommendations regarding potentially dangerous medications shared by representatives of the European Medicines Agency. According to specialists, the therapeutic effect of these drugs gives the volume of the harm they may cause to man.

In particular, the list of drugs, the risk that the use of European doctors rated as "disproportionate to the advantages granted to them" was introduced strontium ranelate - The drug used in the treatment of osteoporosis with a high risk of fractures. From the medical findings it follows that it can lead to serious neurological and cardiovascular disease, fraught with death.

Also, it was recommended by doctors with great caution for patients quinine   - Traditionally used means to combat the attacks of malaria. Quinine is believed physicians, puts the human at risk of developing a number of serious and even fatal side effects, such as severe allergic and anaphylactic reactions, hematological disorders.

Caught in the high risk area and some drugs that are prescribed to patients with Alzheimer's disease . According to experts, these drugs exhibit a "minimal and short-term effectiveness", while capable of causing patients serious side effects, including dangerous as hepatitis. And the most dangerous such funds in combination with other drugs.

Touched experts and some non-prescription tools, freely available in pharmacies. Some of them believe doctors should be entered in the category of prescription. These drugs in particular are considered domperidone Which is used to treat heartburn. (READ MORE)



Industry News

Go back to the main page

Немає коментарів:

Дописати коментар